Overview

GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
Shionogi
Treatments:
Darunavir
Dolutegravir
Etravirine
Lopinavir
Protease Inhibitors
Ritonavir